Cargando…
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A
BACKGROUND: There is a need to identify patients with haemophilia who have a very low or high risk of developing inhibitors. These patients could be candidates for personalized treatment strategies. AIMS: The aim of this study was to externally validate a previously published prediction model for in...
Autores principales: | Hassan, Shermarke, Palla, Roberta, Valsecchi, Carla, Garagiola, Isabella, El‐Beshlawy, Amal, Elalfy, Mohsen, Ramanan, Vijay, Eshghi, Peyman, Karimi, Mehran, Gouw, Samantha Claudia, Mannucci, Pier Mannuccio, Rosendaal, Frits Richard, Peyvandi, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360203/ https://www.ncbi.nlm.nih.gov/pubmed/33988289 http://dx.doi.org/10.1111/hae.14325 |
Ejemplares similares
-
Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia A
por: Spena, Silvia, et al.
Publicado: (2022) -
Management of haemophilia A with inhibitors: A regional cross‐talk
por: Peyvandi, Flora, et al.
Publicado: (2022) -
Haemophilia in the developing countries: the Iranian experience
por: Eshghi, Peyman, et al.
Publicado: (2010) -
Genome-Wide Association Studies in Myocardial Infarction and Coronary Artery Disease
por: Mannucci, Pier Mannuccio, et al.
Publicado: (2010) -
Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)